EW Financial Facts
Research and development expenses: 113.1MCost of goods sold: 201.4M
See Full Income Statement
Additional paid-in capital: 1.09B
Other assets: 124.8M
See Full Balance Sheet
Edwards Lifesciences Corp. (EW) Earnings
|
Expand Research on EW
| Next EPS Date | 4/25/24 | EPS Growth Rate | +3.2% |
|---|---|---|---|
| Average EPS % Beat Rate | +0.8% | Revenue Growth Rate | +8.2% |
| Average % Move 1-Wk after EPS | -5.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/25/24  |
Q124 | N/A | $0.64 | N/A | N/A | $1.58B | = | N/A | N/A | ||
| 1/26/22 |  |
Q421 | $0.51 | $0.55 | -$0.04 | $1.33B | $1.36B | = |  | | Details |
| 4/23/13 |
|
Q113 | $0.72 | $0.76 | -$0.04 | $496.7M | $518.69M |  |
| | Details |
| 1/30/20 | |
Q419 | $1.46 | $1.49 | -$0.03 | $1.2B | $1.14B |  |
| | Details |
| 1/27/21 | |
Q420 | $0.50 | $0.53 | -$0.03 | $1.2B | $1.19B | |
| | Details |
| 10/19/12 |
|
Q312 | $0.58 | $0.61 | -$0.03 | $447.9M | $476.56M | = | | | Details |
| 7/28/22 | |
Q222 | $0.63 | $0.64 | -$0.01 | $1.37B | $1.4B | = | | | Details |
| 7/21/11 |
|
Q211 | $0.49 | $0.50 | -$0.01 | $431.2M | $424.63M | = | | | Details |
